$BHVN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Biohaven Pharmaceutical Holding Co Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Biohaven Pharmaceutical Holding Co Ltd.. Get notifications about new insider transactions in Biohaven Pharmaceutical Holding Co Ltd. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | A | 57.40 | 30,000 | 1,722,000 | 30,000 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | A | 57.40 | 28,000 | 1,607,200 | 28,000 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Option Exercise | A | 57.40 | 10,000 | 574,000 | 10,000 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | A | 57.40 | 25,000 | 1,435,000 | 25,000 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 0.00 | 13,500 | 0 | 13,500 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 57.40 | 25,000 | 1,435,000 | 25,000 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Special Projects & ... | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Special Projects & ... | Option Exercise | A | 57.40 | 5,000 | 287,000 | 5,000 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | A | 0.00 | 14,800 | 0 | 14,800 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | A | 57.40 | 29,500 | 1,693,300 | 29,500 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | A | 0.00 | 43,800 | 0 | 43,800 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | A | 57.40 | 87,500 | 5,022,500 | 87,500 | |
| Oct 25 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 10.82 | 17,700 | 191,514 | 18,500 | |
| Oct 25 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 10.82 | 17,700 | 191,514 | 18,500 | |
| Oct 25 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Sell | S | 45.07 | 17,700 | 797,750 | 0 | 17.7 K to 0 (-100.00 %) |
| Oct 25 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Sell | S | 45.07 | 17,700 | 797,750 | 0 | 17.7 K to 0 (-100.00 %) |
| Oct 25 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 10.82 | 17,700 | 191,514 | 17,700 | 0 to 17.7 K |
| Oct 25 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 10.82 | 17,700 | 191,514 | 17,700 | 0 to 17.7 K |
| Oct 17 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 10.82 | 800 | 8,656 | 36,200 | |
| Oct 17 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Sell | S | 45.01 | 800 | 36,008 | 0 | 800 to 0 (-100.00 %) |
| Oct 17 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 10.82 | 800 | 8,656 | 800 | 0 to 800 |
| Sep 19 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 47.32 | 11,000 | 520,520 | 11,000 | |
| Sep 13 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Option Exercise | M | 25.51 | 10,000 | 255,100 | 20,000 | |
| Sep 13 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Sell | S | 45.00 | 10,000 | 450,000 | 0 | 10 K to 0 (-100.00 %) |
| Sep 13 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Buy | M | 25.51 | 10,000 | 255,100 | 10,000 | 0 to 10 K |
| Aug 21 2019 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Director | Buy | P | 37.65 | 5,000 | 188,250 | 2,587,601 | 2.6 M to 2.6 M (+0.19 %) |
| Jul 01 2019 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | A | 50.85 | 6,000 | 305,100 | 6,000 | |
| Jul 01 2019 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | A | 50.85 | 6,000 | 305,100 | 6,000 | |
| Jun 28 2019 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Buy | P | 43.05 | 2,500 | 107,625 | 2,500 | 0 to 2.5 K |
| Jun 28 2019 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Buy | P | 42.30 | 2,500 | 105,750 | 240,500 | 238 K to 240.5 K (+1.05 %) |
| Jun 26 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Buy | P | 40.22 | 5,000 | 201,100 | 19,130 | 14.1 K to 19.1 K (+35.39 %) |
| Jun 26 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Buy | P | 40.22 | 5,000 | 201,100 | 19,130 | 14.1 K to 19.1 K (+35.39 %) |
| Jun 26 2019 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Director | Buy | P | 40.37 | 10,000 | 403,700 | 10,000 | 0 to 10 K |
| May 23 2019 | BHVN | Biohaven Pharmaceu ... | GREGORY JULIA P | Director | Option Exercise | A | 61.76 | 18,000 | 1,111,680 | 18,000 | |
| May 23 2019 | BHVN | Biohaven Pharmaceu ... | Repella Robert | Director | Option Exercise | A | 61.76 | 18,000 | 1,111,680 | 18,000 | |
| May 23 2019 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Director | Option Exercise | A | 61.76 | 18,000 | 1,111,680 | 18,000 | |
| May 23 2019 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Director | Option Exercise | A | 61.76 | 18,000 | 1,111,680 | 18,000 | |
| May 23 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Option Exercise | A | 61.76 | 18,000 | 1,111,680 | 18,000 | |
| May 23 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Option Exercise | A | 61.76 | 18,000 | 1,111,680 | 18,000 | |
| Apr 16 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 61.92 | 50,000 | 3,096,000 | 926,002 | 976 K to 926 K (-5.12 %) |
| Apr 16 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 53.92 | 38,825 | 2,093,444 | 976,002 | 1 M to 976 K (-3.83 %) |
| Apr 05 2019 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Director | Option Exercise | M | 9.29 | 107,500 | 998,675 | 0 | |
| Apr 05 2019 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Director | Buy | M | 9.29 | 107,500 | 998,675 | 2,582,601 | 2.5 M to 2.6 M (+4.34 %) |
| Apr 05 2019 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Director | Option Exercise | M | 9.29 | 107,500 | 998,675 | 0 | |
| Apr 05 2019 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Director | Buy | M | 9.29 | 107,500 | 998,675 | 107,500 | 0 to 107.5 K |
| Apr 03 2019 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | A | 50.72 | 80,000 | 4,057,600 | 80,000 | |
| Mar 26 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 53.72 | 5,824 | 312,865 | 1,014,827 | 1 M to 1 M (-0.57 %) |
| Mar 26 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 53.66 | 5,351 | 287,135 | 1,020,651 | 1 M to 1 M (-0.52 %) |
| Mar 14 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 9.29 | 10,000 | 92,900 | 78,792 | |
| Mar 14 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Sell | S | 50.11 | 10,000 | 501,100 | 0 | 10 K to 0 (-100.00 %) |
| Mar 14 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 9.29 | 10,000 | 92,900 | 10,000 | 0 to 10 K |
| Mar 14 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 50.03 | 15,783 | 789,623 | 440,000 | 455.8 K to 440 K (-3.46 %) |
| Mar 14 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 50.02 | 16,110 | 805,822 | 475,000 | 491.1 K to 475 K (-3.28 %) |
| Mar 14 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 50.02 | 8,262 | 413,265 | 455,783 | 464 K to 455.8 K (-1.78 %) |
| Mar 14 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 50.02 | 7,883 | 394,308 | 491,110 | 499 K to 491.1 K (-1.58 %) |
| Mar 14 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 50.15 | 25,955 | 1,301,643 | 464,045 | 490 K to 464 K (-5.30 %) |
| Mar 14 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 50.15 | 26,007 | 1,304,251 | 498,993 | 525 K to 499 K (-4.95 %) |
| Mar 01 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 47.19 | 50,000 | 2,359,500 | 1,026,002 | 1.1 M to 1 M (-4.65 %) |
| Mar 01 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 45.41 | 595 | 27,019 | 1,076,002 | 1.1 M to 1.1 M (-0.06 %) |
| Mar 01 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 45.71 | 23,384 | 1,068,883 | 1,076,597 | 1.1 M to 1.1 M (-2.13 %) |
| Mar 01 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 45.86 | 1,900 | 87,134 | 373,913 | 375.8 K to 373.9 K (-0.51 %) |
| Mar 01 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 45.25 | 18,270 | 826,718 | 375,813 | 394.1 K to 375.8 K (-4.64 %) |
| Mar 01 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 44.17 | 6,875 | 303,669 | 394,083 | 401 K to 394.1 K (-1.71 %) |
| Feb 26 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 45.49 | 13,943 | 634,267 | 1,099,981 | 1.1 M to 1.1 M (-1.25 %) |
| Feb 26 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 44.81 | 100 | 4,481 | 400,958 | 401.1 K to 401 K (-0.02 %) |
| Feb 26 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 44.31 | 20,796 | 921,471 | 401,058 | 421.9 K to 401.1 K (-4.93 %) |
| Feb 26 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 45.74 | 100 | 4,574 | 421,854 | 422 K to 421.9 K (-0.02 %) |
| Feb 26 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 45.25 | 20,334 | 920,114 | 421,954 | 442.3 K to 422 K (-4.60 %) |
| Feb 26 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 44.97 | 16,050 | 721,769 | 442,288 | 458.3 K to 442.3 K (-3.50 %) |
| Feb 26 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 44.11 | 5,575 | 245,913 | 458,338 | 463.9 K to 458.3 K (-1.20 %) |
| Feb 25 2019 | BHVN | Biohaven Pharmaceu ... | GREGORY JULIA P | Director | Option Exercise | M | 23.63 | 12,000 | 283,560 | 24,000 | |
| Feb 25 2019 | BHVN | Biohaven Pharmaceu ... | GREGORY JULIA P | Director | Sell | S | 43.56 | 12,000 | 522,720 | 0 | 12 K to 0 (-100.00 %) |
| Feb 25 2019 | BHVN | Biohaven Pharmaceu ... | GREGORY JULIA P | Director | Buy | M | 23.63 | 12,000 | 283,560 | 12,000 | 0 to 12 K |
| Feb 25 2019 | BHVN | Biohaven Pharmaceu ... | GREGORY JULIA P | Director | Option Exercise | M | 23.63 | 12,000 | 283,560 | 24,000 | |
| Feb 25 2019 | BHVN | Biohaven Pharmaceu ... | GREGORY JULIA P | Director | Sell | S | 43.56 | 12,000 | 522,720 | 0 | 12 K to 0 (-100.00 %) |
| Feb 25 2019 | BHVN | Biohaven Pharmaceu ... | GREGORY JULIA P | Director | Buy | M | 23.63 | 12,000 | 283,560 | 12,000 | 0 to 12 K |
| Feb 20 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 45.51 | 1,400 | 63,714 | 1,113,924 | 1.1 M to 1.1 M (-0.13 %) |
| Feb 20 2019 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 45.42 | 678 | 30,795 | 1,115,324 | 1.1 M to 1.1 M (-0.06 %) |
| Feb 06 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Option Exercise | M | 20.79 | 7,609 | 158,191 | 22,827 | |
| Feb 06 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Option Exercise | M | 25.51 | 10,000 | 255,100 | 30,000 | |
| Feb 06 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Sell | M | 42.54 | 17,609 | 749,087 | 0 | 17.6 K to 0 (-100.00 %) |
| Feb 06 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Buy | M | 20.79 | 7,609 | 158,191 | 17,609 | 10 K to 17.6 K (+76.09 %) |
| Feb 06 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Buy | M | 25.51 | 10,000 | 255,100 | 10,000 | 0 to 10 K |
| Jan 14 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 9.29 | 10,500 | 97,545 | 10,500 | |
| Jan 14 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Sell | S | 37.67 | 10,500 | 395,535 | 0 | 10.5 K to 0 (-100.00 %) |
| Jan 14 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 9.29 | 10,500 | 97,545 | 10,500 | 0 to 10.5 K |
| Dec 06 2018 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 41.95 | 40,000 | 1,678,000 | 1,156,002 | 1.2 M to 1.2 M (-3.34 %) |
| Sep 11 2018 | BHVN | Biohaven Pharmaceu ... | Repella Robert | Director | Option Exercise | A | 35.50 | 36,000 | 1,278,000 | 36,000 | |
| Jun 19 2018 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | VP of Operations | Option Exercise | M | 0.61 | 12,500 | 7,625 | 25,000 | |
| Jun 19 2018 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | VP of Operations | Sell | S | 40.02 | 12,500 | 500,250 | 0 | 12.5 K to 0 (-100.00 %) |
| Jun 19 2018 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | VP of Operations | Buy | M | 0.61 | 12,500 | 7,625 | 12,500 | 0 to 12.5 K |
| Jun 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 38.00 | 5,629 | 213,902 | 234,551 | 240.2 K to 234.6 K (-2.34 %) |
| Jun 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 37.07 | 10,647 | 394,684 | 240,180 | 250.8 K to 240.2 K (-4.24 %) |
| Jun 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 38.00 | 1,377 | 52,326 | 550,000 | 551.4 K to 550 K (-0.25 %) |
| Jun 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 37.07 | 2,604 | 96,530 | 551,377 | 554 K to 551.4 K (-0.47 %) |
| Jun 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 36.65 | 100 | 3,665 | 250,827 | 250.9 K to 250.8 K (-0.04 %) |
| Jun 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 36.15 | 55,907 | 2,021,038 | 250,927 | 306.8 K to 250.9 K (-18.22 %) |
| Jun 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 35.25 | 4,409 | 155,417 | 306,834 | 311.2 K to 306.8 K (-1.42 %) |
| Jun 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 36.16 | 13,858 | 501,105 | 553,981 | 567.8 K to 554 K (-2.44 %) |
| Jun 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 35.25 | 1,218 | 42,935 | 567,839 | 569.1 K to 567.8 K (-0.21 %) |
| Jun 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 36.01 | 6,735 | 242,527 | 320,692 | 327.4 K to 320.7 K (-2.06 %) |
| Jun 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 36.01 | 1,671 | 60,173 | 569,057 | 570.7 K to 569.1 K (-0.29 %) |
| Jun 07 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 36.01 | 2,003 | 72,128 | 327,427 | 329.4 K to 327.4 K (-0.61 %) |
| Jun 07 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 36.01 | 497 | 17,897 | 570,728 | 571.2 K to 570.7 K (-0.09 %) |
| Jun 07 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 36.01 | 13,608 | 490,024 | 329,430 | 343 K to 329.4 K (-3.97 %) |
| Jun 07 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 36.01 | 3,375 | 121,534 | 571,225 | 574.6 K to 571.2 K (-0.59 %) |
| Jun 07 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 36.02 | 4,962 | 178,731 | 343,038 | 348 K to 343 K (-1.43 %) |
| Jun 07 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 36.00 | 1,400 | 50,400 | 574,600 | 576 K to 574.6 K (-0.24 %) |
| Jun 06 2018 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 36.00 | 300 | 10,800 | 1,196,002 | 1.2 M to 1.2 M (-0.03 %) |
| Jun 06 2018 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 35.41 | 49,463 | 1,751,485 | 1,196,302 | 1.2 M to 1.2 M (-3.97 %) |
| Jun 06 2018 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 35.05 | 39,453 | 1,382,828 | 1,245,765 | 1.3 M to 1.2 M (-3.07 %) |
| Jun 01 2018 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 35.04 | 83,898 | 2,939,786 | 1,285,218 | 1.4 M to 1.3 M (-6.13 %) |
| Jun 01 2018 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 35.01 | 26,044 | 911,800 | 1,369,116 | 1.4 M to 1.4 M (-1.87 %) |
| Jun 01 2018 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Sell | S | 35.00 | 842 | 29,470 | 1,395,160 | 1.4 M to 1.4 M (-0.06 %) |
| Jun 01 2018 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 35.04 | 5,229 | 183,224 | 525,000 | 530.2 K to 525 K (-0.99 %) |
| Jun 01 2018 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 35.04 | 8,611 | 301,729 | 525,000 | 533.6 K to 525 K (-1.61 %) |
| Jun 01 2018 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 35.01 | 18,971 | 664,175 | 530,229 | 549.2 K to 530.2 K (-3.45 %) |
| Jun 01 2018 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 35.01 | 15,648 | 547,836 | 533,611 | 549.3 K to 533.6 K (-2.85 %) |
| Jun 01 2018 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 35.00 | 800 | 28,000 | 549,200 | 550 K to 549.2 K (-0.15 %) |
| Jun 01 2018 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 35.00 | 741 | 25,935 | 549,259 | 550 K to 549.3 K (-0.13 %) |
| May 30 2018 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | M | 0.61 | 5,000 | 3,050 | 17,500 | |
| May 30 2018 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Sell | S | 35.00 | 5,000 | 175,000 | 0 | 5 K to 0 (-100.00 %) |
| May 30 2018 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Buy | M | 0.61 | 5,000 | 3,050 | 5,000 | 0 to 5 K |
| May 14 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 27.52 | 1,520 | 41,830 | 348,000 | 349.5 K to 348 K (-0.43 %) |
| May 14 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 26.78 | 26,480 | 709,134 | 349,520 | 376 K to 349.5 K (-7.04 %) |
| May 14 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 27.52 | 380 | 10,458 | 576,000 | 576.4 K to 576 K (-0.07 %) |
| May 14 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 26.78 | 6,620 | 177,284 | 576,380 | 583 K to 576.4 K (-1.14 %) |
| May 03 2018 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Director | Option Exercise | A | 28.76 | 18,000 | 517,680 | 18,000 | |
| May 03 2018 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Director | Option Exercise | A | 28.76 | 18,000 | 517,680 | 18,000 | |
| May 03 2018 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Director | Option Exercise | A | 28.76 | 18,000 | 517,680 | 18,000 | |
| May 03 2018 | BHVN | Biohaven Pharmaceu ... | GREGORY JULIA P | Director | Option Exercise | A | 28.76 | 18,000 | 517,680 | 18,000 | |
| May 03 2018 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Option Exercise | A | 28.76 | 18,000 | 517,680 | 18,000 | |
| Apr 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 25.81 | 80 | 2,065 | 376,000 | 376.1 K to 376 K (-0.02 %) |
| Apr 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 25.39 | 10,880 | 276,243 | 376,080 | 387 K to 376.1 K (-2.81 %) |
| Apr 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 24.19 | 17,040 | 412,198 | 386,960 | 404 K to 387 K (-4.22 %) |
| Apr 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 25.81 | 20 | 516 | 583,000 | 583 K to 583 K (0.00 %) |
| Apr 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 25.39 | 2,720 | 69,061 | 583,020 | 585.7 K to 583 K (-0.46 %) |
| Apr 12 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 24.19 | 4,260 | 103,049 | 585,740 | 590 K to 585.7 K (-0.72 %) |
| Mar 15 2018 | BHVN | Biohaven Pharmaceu ... | Cha Albert | Director | Grant | A | 27.50 | 72,727 | 1,999,993 | 2,049,545 | 2 M to 2 M (+3.68 %) |
| Mar 14 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 30.68 | 2,360 | 72,405 | 404,000 | 406.4 K to 404 K (-0.58 %) |
| Mar 14 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 30.06 | 25,640 | 770,738 | 406,360 | 432 K to 406.4 K (-5.94 %) |
| Mar 14 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 30.68 | 590 | 18,101 | 590,000 | 590.6 K to 590 K (-0.10 %) |
| Mar 14 2018 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 30.06 | 6,410 | 192,685 | 590,590 | 597 K to 590.6 K (-1.07 %) |
| Mar 05 2018 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | VP of Operations | Option Exercise | M | 0.61 | 5,000 | 3,050 | 37,500 | |
| Mar 05 2018 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | VP of Operations | Sell | S | 33.44 | 2,200 | 73,568 | 0 | 2.2 K to 0 (-100.00 %) |
| Mar 05 2018 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | VP of Operations | Sell | S | 32.42 | 2,800 | 90,776 | 2,200 | 5 K to 2.2 K (-56.00 %) |